Recent Quotes (30 days)

You have no recent quotes
chg | %

Helix Biopharma Corp.  

(Public, TSE:HBP)   Watch this stock  
Find more results for hbp
+0.09 (6.43%)
Apr 16 - Close
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 1.44 - 1.49
52 week 0.50 - 1.77
Open 1.44
Vol / Avg. 173,170.00/5,262.00
Mkt cap 107.14M
P/E     -
Div/yield     -
EPS -0.12
Shares 71.90M
Beta 0.70
Inst. own 0%
Apr 1, 2014
Q2 2014 Helix BioPharma Corp. Earnings Release (Estimated)

Key stats and ratios

Q4 (Oct '13) 2013
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -179.36% -121.54%
Return on average equity -221.74% -147.06%
Employees 2 -
CDP Score - -


Unit 3, 305 Industrial Parkway South
+1-905-8412300 (Phone)
+1-905-8412244 (Fax)

Website links


Helix BioPharma Corp. (Helix) is a biopharmaceutical company focused on cancer therapy. Helix is developing products for the treatment and prevention of cancer based on its technologies. The Company�s product development initiatives have focused on its L-DOS47 and Topical Interferon Alpha-2b new drug candidates. As of July 31, 2012, the Company derived its revenue from distribution in Canada from Klean-Prep1, Orthovisc1, Monovisc1, Immunovir1 and Normacol1. The Company has a profitable distribution business in Canada. The products distributed in Canada include Orthovisc and Monovisc, treatments for osteoarthritis of the knee; Klean-Prep and Normacol, gastrointestinal products, and Imunovir, an immune system modulating drug. During the fiscal year ended July 31, 2012 (fiscal 2012), its product revenue derived mainly from the sale in Canada of Klean-Prep, Orthovisc and Monovisc. In August 2013, Helix BioPharma Corp established a Polish subsidiary (Helix Polska).

Officers and directors

Robert A. Verhagen Interim Chairman of the Board, President, Chief Executive Officer
Age: 44
Photios Michalargias Chief Financial Officer
Age: 50
Heman Chao Ph.D. Chief Scientific Officer
Age: 51
Sylwester Cacek Director
Yvon Bastien Independent Director
Age: 66
Slawomir Majewski M.D. Independent Director
Age: 57
Marek Orlowski Independent Director
Age: 45
Sven Rohmann Independent Director
Age: 51